Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (2)
  • 2025 (17)
  • 2024 (23)
  • 2023 (47)
  • 2022 (68)
  • 2021 (58)
  • 2020 (8)
  • 2019 (8)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Overdose (324)
  • Major Law Enforcement Operation (274)
  • Diversion Division (250)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (158)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Intergovernmental Affairs (9)

Drug Name

  • Oxycodone (48)
  • Opioids (45)
  • Fentanyl (28)
  • Hydromorphone (14)
  • Synthetic Opioids (12)
  • Morphine (8)
  • Benzodiazepines (7)
  • Cocaine (4)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Heroin (1)

Field Division

  • Washington, DC (37)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (17)
  • Sede (13)
  • Atlanta (12)
  • New Jersey (12)
  • El Paso (10)
  • Dallas (8)
  • Seattle (8)
  • Houston (7)
  • San Francisco (7)
  • San Diego (6)
  • Louisville (5)
  • New England (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
Clear All Results
235 Results - Showing 171 to 180
PRESS RELEASE

Doctor Charged With Accepting Bribes in Exchange for Fentanyl

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a Monmouth County, New Jersey, doctor was charged today for his participation in a scheme to receive bribes...
PRESS RELEASE

MS-13 Honduras Leader and Drug Supplier Charged

WASHINGTON, D.C. - Damian Williams, the United States Attorney for the Southern District of New York, John J. Durham, Director of Joint Task Force Vulcan (“JTFV”), Anne Milgram, Administrator of the Drug Enforcement Administration (“DEA”), Jay Greenberg, Acting Assistant Director of the Criminal Investigative Division of the Federal Bureau of...
PRESS RELEASE

Ringleader and Members of Multi-State Anabolic Steroid Trafficking Network Sentenced

NORFOLK, Va. – Today, a Richmond man was the sixth and final defendant to be sentenced for his role in a multi-state anabolic steroid conspiracy that operated across the country. According to court documents, Clyde Edward Peele, 46, is one of six members of a trafficking network, led by Michael...
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Brings in 745,000 Pounds of Unneeded Medications, Continues Fight Against Opioid Epidemic

Washington, D.C., – The DEA, along with its law enforcement partners, removed close to 745,000 pounds of unneeded prescriptions from medicine cabinets across the country this past Saturday, October 23rd, as part of DEA’s ongoing commitment to turn the tide against the U.S. opioid epidemic. Following last month’s 21st National...
PRESS RELEASE

DEA Holds National Prescription Drug Take Back Day to Turn the Tide Against the U.S. Opioid Epidemic

DALLAS– The Drug Enforcement Administration will host its 21st National Prescription Drug Take Back Day on Saturday, October 23 from 10 a.m. to 2 p.m. This event offers free and anonymous disposal of unneeded medications at more than 4,000 local drop-off locations nationwide. According to a report published by the...
PRESS RELEASE

Former Long Island Doctor Sentenced for Conspiring to Illegally Distribute Oxycodone

CENTRAL ISLIP, N.Y. – Earlier today, in federal court in Central Islip, Tameshwar Ammar, a former medical doctor in Roslyn, New York, was sentenced by United States District Judge Denis R. Hurley to five years’ imprisonment for conspiring to illegally distribute oxycodone. In June 2020, Ammar relinquished his license to...
PRESS RELEASE

Long Island Doctor Convicted of Illegal Distribution of Oxycodone

CENTRAL ISLIP, N.Y. - A federal jury in Central Islip returned a guilty verdict this afternoon against Frank Parasmo, a medical doctor with an office in Deer Park, on 31 counts of unlawfully distributing oxycodone, a highly addictive prescription painkiller, and one count of unlawfully distributing hydrocodone, all without a...
PRESS RELEASE

Creve Coeur Pharmacy and Owner to Pay $1.4 Million for Ignoring Signs of Illegal Drug Prescriptions

ST. LOUIS – Olive Street Pharmacy, LLC, and pharmacy technician Irina Shlafshteyn, agreed to pay $1,507,808.50 to resolve a civil complaint bringing claims under the False Claims Act and Controlled Substances Act related to the unlawful dispensing of controlled substances, including some that were submitted to Medicaid or Medicare for...

Paginación

  • Primera página «
  • Anterior
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Current page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster